Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine

Sophia Harringer, Michaela Hejl, Éva A. Enyedy, Michael A. Jakupec, Mathea S. Galanski, Bernhard K. Keppler, Paul J. Dyson and Hristo P. Varbanov

Dalton Trans., 2021, 50, 8167
DOI: 10.1039/D1DT00214G

Tacrine–deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug

Karam Chand, Karam Rajeshwari, Emanuel Candeias, Sandra M Cardoso, Sílvia Chaves and M Amélia Santos

Metallomics, 2018, 10, 1460
DOI: 10.1039/c8mt00143j

Cell Permeable Imidazole-Desferrioxamine Conjugates: Synthesis and In Vitro Evaluation

Shreya Pramanik, Saikat Chakraborty, Malavika Sivan, Birija S. Patro, Sucheta Chatterjee and Dibakar Goswami

Bioconjugate Chem., 2019, 30, 841
DOI: 10.1021/acs.bioconjchem.8b00924

Convergent Synthesis of Macrocyclic and Linear Desferrioxamines

Cheng‐Hsin Chiu, Ting‐Cian Jheng, Bo‐Chun Peng, Wen‐Sheng Chung and Kwok‐Kong Tony Mong

Eur J Org Chem, 2020, 2020, 3650
DOI: 10.1002/ejoc.202000439

Small molecule regulation of iron homeostasis: design and optimization of novel iron chelators based on a thiosemicarbazone scaffold

Christian S. Parry, Yue Li, Samuel Kojo Kwofie, Josh Valencia, Cynthia A. Tope Niedermaier, Timothy R. Ramadhar, Sergei Nekhai, Michael D. Wilson and Raymond J. Butcher

Journal of Molecular Structure, 2025, 1334, 141859
DOI: 10.1016/j.molstruc.2025.141859

Advances in the Chemical Biology of Desferrioxamine B

Rachel Codd, Tomas Richardson-Sanchez, Thomas J. Telfer and Michael P. Gotsbacher

ACS Chem. Biol., 2018, 13, 11
DOI: 10.1021/acschembio.7b00851

Unlocking molecular secrets: The role of miRNAs in Parkinson's disease dynamics

Rehab A. Ismail, Mohamed Abobakr, Mostafa Mohamed, Ahmed Hussieny, Mohamed Alaa, Mostafa tarek and Shereen Saeid Elshaer

Neuropharmacology, 2025, 278, 110542
DOI: 10.1016/j.neuropharm.2025.110542

Recent Advances in Zirconium-89 Chelator Development

Nikunj Bhatt, Darpan Pandya and Thaddeus Wadas

Molecules, 2018, 23, 638
DOI: 10.3390/molecules23030638

The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson’s Disease

Minrui Weng, Xiaoji Xie, Chao Liu, Kah-Leong Lim, Cheng-wu Zhang and Lin Li

Parkinson's Disease, 2018, 2018, 1
DOI: 10.1155/2018/9163040

Chemical reactivity and uses of 1-phenyl-3-methyl-5-pyrazolone (PMP), also known as edaravone

Christian Bailly, Paul-Emile Hecquet, Mostafa Kouach, Xavier Thuru and Jean-François Goossens

Bioorganic & Medicinal Chemistry, 2020, 28, 115463
DOI: 10.1016/j.bmc.2020.115463

Overdosing on iron: Elevated iron and degenerative brain disorders

Santosh R D’Mello and Mark C Kindy

Exp Biol Med (Maywood), 2020, 245, 1444
DOI: 10.1177/1535370220953065

The role of the iron-chelating agent deferoxamine in spinal cord injury: a systematic review and meta-analysis of preclinical studies

Mehrnaz Moradi, Amirhossein Najibi, Reza Moshfeghinia, Afshin Heidarian, Mehrpour Moradi and Michael G. Fehlings

The Spine Journal, 2025
DOI: 10.1016/j.spinee.2025.07.030

Analogues of desferrioxamine B (DFOB) with new properties and new functions generated using precursor-directed biosynthesis

Thomas J. Telfer, Tomas Richardson-Sanchez, Michael P. Gotsbacher, Kate P. Nolan, William Tieu and Rachel Codd

Biometals, 2019, 32, 395
DOI: 10.1007/s10534-019-00175-7

Protection of Iron-Induced Oxidative Damage in Neuroblastoma (SH-SY5Y) Cells by Combination of 1-(N-Acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one and Green Tea Extract

Nittaya Chansiw, Kanokwan Kulprachakarn, Narisara Paradee, Adchara Prommaban, Somdet Srichairatanakool and Franc Perdih

Bioinorganic Chemistry and Applications, 2021, 2021, 1
DOI: 10.1155/2021/5539666

Desferrioxamine and dextromethorphan combination exhibited synergistic effect and reversed the catalepsy behaviour in 6-hydroxydopamine hydroydopamine administered rats through regulating brain glutamate levels

Navaf Mannan Thodukayil, Justin Antony, Peet Thomas, Victoria Jeyarani, Tenzin Choephel, Chennu Manisha, Asha Jose, Santilna Karolina Sahadevan and Elango Kannan

Journal of Pharmacy and Pharmacology, 2019, 71, 1271
DOI: 10.1111/jphp.13109

Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer’s Disease, Parkinson’s Disease, and Intracerebral Hemorrhage

Amy Corbin Farr and May P. Xiong

Mol. Pharmaceutics, 2021, 18, 593
DOI: 10.1021/acs.molpharmaceut.0c00474

Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention

Shreyak Sharma and David E. Leaf

JASN, 2019, 30, 2060
DOI: 10.1681/ASN.2019060595

Structural Basis for Xenosiderophore Utilization by the Human Pathogen Staphylococcus aureus

Nathaniel P. Endicott, Eries Lee and Timothy A. Wencewicz

ACS Infect. Dis., 2017, 3, 542
DOI: 10.1021/acsinfecdis.7b00036

Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration

Shalini S. Rao and Paul Anthony Adlard

Front. Mol. Neurosci., 2018, 11
DOI: 10.3389/fnmol.2018.00276

Exploring the potential of repurposed deferoxamine: bridging challenges and novel formulation opportunities

Soumyadip Mukherjee, Akhila Reddy, Nikita Dutta, Klaudi K. Vaiphei, Vivek, Ankaj Kumar and Arvind Gulbake

Nanomedicine, 2025, 20, 2117
DOI: 10.1080/17435889.2025.2534318

Acetyl-CoA-Mediated Post-Biosynthetic Modification of Desferrioxamine B Generates N- and N-O-Acetylated Isomers Controlled by a pH Switch

Kate P. Nolan, Josep Font, Athavan Sresutharsan, Michael P. Gotsbacher, Christopher J. M. Brown, Renae M. Ryan and Rachel Codd

ACS Chem. Biol., 2022, 17, 426
DOI: 10.1021/acschembio.1c00879

Azido‐Desferrioxamine Siderophores as Functional Click‐Chemistry Probes Generated in Culture upon Adding a Diazo‐Transfer Reagent

Michael P. Gotsbacher and Rachel Codd

ChemBioChem, 2020, 21, 1433
DOI: 10.1002/cbic.201900661

The Hidden Notes of Redox Balance in Neurodegenerative Diseases

Silvia Piccirillo, Simona Magi, Alessandra Preziuso, Tiziano Serfilippi, Giorgia Cerqueni, Monia Orciani, Salvatore Amoroso and Vincenzo Lariccia

Antioxidants, 2022, 11, 1456
DOI: 10.3390/antiox11081456

Synthesis of 4-Aminopyrazol-5-ols as Edaravone Analogs and Their Antioxidant Activity

Yanina V. Burgart, Galina F. Makhaeva, Olga P. Krasnykh, Sophia S. Borisevich, Natalia A. Agafonova, Nadezhda V. Kovaleva, Natalia P. Boltneva, Elena V. Rudakova, Evgeny V. Shchegolkov, Galina A. Triandafilova, Denis A. Gazizov, Olga G. Serebryakova, Maria V. Ulitko, Sergey L. Khursan, Victor I. Saloutin and Rudy J. Richardson

Molecules, 2022, 27, 7722
DOI: 10.3390/molecules27227722